accepted and acknowledged
on 08 Apr 2024
Last Applicant/ Owned by
CONNAUGHT HOUSE
DUBLIN 4
IE
Serial Number
87276061 filed on 21st Dec 2016
Registration Number
5581432 registered on 09th Oct 2018
Correspondent Address
Norm J. Rich
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervouRead More
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
16th Jul 2018
16th Jul 2018
No 87276061
No Service/Collective Mark
No 029318-2683
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 08th Apr 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 08th Apr 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 08th Apr 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 11th Oct 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 09th Oct 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 09th Oct 2018 | REGISTERED-PRINCIPAL REGISTER |
| 04th Sep 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 01st Sep 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 16th Aug 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| 14th Aug 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
